StonvexLoading…
StonvexStonvexStonvexCore line items from IDR's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
Quarterly filings sourced directly from SEC EDGAR. Real-time earnings actuals are in the Earnings panel above.
| Metric | Q3 2026 (Est.) Expected 2026-08-05 | Q3 2025 2025-09-30 | Q2 2025 2025-06-30 | Q1 2025 2025-03-31 | Annual 2024 2024-12-31 |
|---|---|---|---|---|---|
Revenue | $13.43M | $27.84M | $16.76M | $7.28M | $25.77M |
Operating Income | Not available | $6.51M | $3.92M | $1.40M | $8.43M |
Net Income | Not available | $7.35M | $4.38M | $1.61M | $8.84M |
EPS (Diluted) | $0.27 | $0.51 | $0.31 | $0.12 | $0.67 |
Total Assets | Not available | $83.11M | $57.70M | $48.07M | $44.02M |
Total Liabilities | Not available | $6.17M | $5.70M | $5.56M | $3.61M |
Cash & Equivalents | Not available | $3.78M | $2.44M | $1.31M | $1.11M |
Free Cash Flow OCF − CapEx | Not available | $4.23M | $3.52M | $1.01M | $8.62M |
Shares Outstanding | Not available | 15.09M | 14.06M | 13.67M | 13.67M |